Association Between Vascular Calcification Scores on Plain Radiographs and Fatty Acid Contents of Erythrocyte Membrane in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 22, Issue 1, 2012, Pages 58-66

  Son, Young K ^a   Lee, Su M ^a   Kim, Seong E ^a   Kim, Ki H ^a   Lee, Seon Y ^a   Bae, Hae R ^a   Han, Jin Y ^a   Park, Yongsoon ^b   An, Won S ^a  

^a Dong A University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; ERYTHROCYTE MEMBRANE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MIDDLE AGED; RADIOGRAPHY; RENAL REPLACEMENT THERAPY;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHROMATOGRAPHY, GAS; CROSS-SECTIONAL STUDIES; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OLEIC ACID; RENAL DIALYSIS; TRIGLYCERIDES; VASCULAR CALCIFICATION;

ANIMALIA;

EID: 84855201140     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.01.023     Document Type: Article

References (46)

1. Foley R.N., Parfrey P.S., Sarnak M.J., et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32(suppl 3):112-119.
2. Collins A.J., Kasiske B., Herzog C., et al. Experts from the Unites States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the Unites States. Am J Kidney Dis 2003, 42(suppl 5):1-230.
3. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
4. An W.S., Kim S.E., Kim K.H., et al. Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients. J Korean Med Sci 2009, 24(suppl):S115-S120.
5. Adragao T., Pires A., Lucas C., et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Tranplant 2004, 19:1480-1488.
6. Okuno S., Ishimura E., Kitatani K., et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007, 49:417-425.
7. Matsuoka M., Iseki K., Tamashiro M., et al. Impact of high coronary artery calcification scores (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004, 8:54-58.
8. Shoji T., Nishizawa Y., Kawagishi T., et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis 1997, 131:229-236.
9. Nishizawa Y., Shoji T., Kawagishi T., et al. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. Kidney Int 1997, 52:S90-S92.
10. Attman P.O., Samuelsson O., Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993, 21:573-592.
11. Tamashiro M., Iseki K., Sunagawa O., et al. Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 2001, 38:64-69.
12. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65:1645S-1654S.
13. Schmidt E.B. N-3 fatty acids and the risk of coronary heart disease. Dan Med Bull 1997, 44:1-22.
14. Schlemmer C.K., Coetzer H., Claassen N., et al. Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1998, 59:221-227.
15. Burgess N.A., Reynolds T.M., Williams N., et al. Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res 1995, 23:239-242.
16. Harris W.S., Sands S.A., Windsor S.L., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 21:1645-1649.
17. Ma D.W., Seo J., Switzer K.C., et al. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004, 15:700-706.
18. Li Q., Wang M., Tan L., et al. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res 2005, 46:1904-1914.
19. Mizobuchi M., Towler D., Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009, 20:1453-1464.
20. Wilson P.W., Kauppila L.I., O'Donnel C.J., et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001, 103:1529-1534.
21. Kauppila L.I., Polak J.F., Cupples L.A., et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
22. Honkanen E., Kauppila L., Wikstrom B., et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008, 23:4009-4015.
23. Alber C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Eng J Med 2002, 346:1113-1118.
24. Park Y., Lim J., Lee J., et al. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br J Nutr 2009, 102:1355-1361.
25. Block R.C., Harris W.S., Reid K.J., et al. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008, 197:821-828.
26. Block R.C., Harris W.S., Reid K.J., et al. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?. Am Heart J 2008, 156:1117-1123.
27. Keys A., Menotti A., Karvonen M.J., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1985, 124:903-915.
28. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., et al. Major types of dietary fat and risk of coronary heart disease; a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
29. Siguel E.N., Lerman R.H. Altered fatty acid metabolism in patients with angiographically documented coronary artery disease. Metabolism 1994, 43:982-993.
30. Paganelli F., Maixent J.M., Duran M.J., et al. Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Int J Cardiol 2001, 78:27-32.
31. An W.S., Kim S.E., Kim K.H., et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Ren Nutr 2009, 19:267-274.
32. Koorts A.M., Viljeon M., Kruger M.C. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids 2002, 67:13-18.
33. Ruíz-Gutiérrez V., Muriana F.J., Guerrero A., et al. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J Hypertens 1996, 14:1483-1490.
34. Garg A., Bonanome A., Grundy S.M., et al. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988, 319:829-834.
35. Allison M.A., Pavlinac P., Wright C.M. The differential associations between HDL, non-HDL and total cholesterols and atherosclerotic calcium deposits in multiple vascular beds. Atherosclerosis 2007, 194:e87-e94.
36. Yao Y., Shao E.S., Jumabay M., et al. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the acyivin-like kinase receptor 1 and 2. Atheroscler Thromb Vasc Biol 2008, 28:2264-2274.
37. Harris W.S., Miller M., Tighe A.P., et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
38. Hamazaki T., Urakaze M., Sawazaki S., et al. Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis 1988, 73:157-160.
39. Hall W.L., Sanders K.A., Sanders T.A., et al. A high-fat meal enriched with eicosapentaenoic acid reduces postprandial arterial stiffness measured by digital volume pulse analysis in healthy men. J Nutr 2008, 138:287-291.
40. Nishizawa H., Hamazaki K., Hamazaki T., et al. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo 2006, 20:307-310.
41. Tomiyama H., Takazawa K., Osa S., et al. Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study. Hypertens Res 2005, 28:651-655.
42. Adragão T., Pires A., Birne R., et al. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 2009, 24:997-1002.
43. Heine-Bröring R.C., Brouwer I.A., Proença R.V., et al. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr 2010, 9:1317-1323.
44. Mathew S., Lund R.J., Chaudhary L.R., et al. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 2008, 19:1509-1519.
45. Mizobuchi M., Finch J.L., Martin D.R., et al. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 2007, 72:709-715.
46. Matias P.J., Ferreira C., Jorge C., et al. 25-hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009, 24:611-618.